About: Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins »

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins » Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins »
Creator	Tangy, Frédéric Le Grand, Roger Autran, Brigitte Launay, Odile Combadière, Béhazine Garçon, Nathalie Locht, Camille Verger, Pierre
Source	Elsevier; Medline; PMC
abstract	SUMMARY The explosion of vaccines during the 20th century allowed the control of numerous infectious plagues but multiple challenges oppose conservation and extension of these successes. The hesitation of modern societies in front of vaccinations requires researches in life, human and social sciences in order to reach a better understanding of vaccines mechanism of action and to improve the tolerance and acceptability of vaccines and additives. The ageing of the populations and the increase of subjects at risk also require to improve the immunogenicity and the efficiency of existing vaccines. The constant emergence of new epidemics or the development of the antibio-resistance imposes innovation and development of new vaccines. The recent difficulties faced by the development of vaccines against malaria, tuberculosis or AIDS illustrate the necessity of moving beyond classical recipes and of elaborating new vectors and new adjuvants, of better understanding the heterogeneity of vaccine immunity and of developing alternative routes of immunization. Multidisciplinary researches using the most recent advances in molecular, structural and cellular biology, in microbiology, immunology and of genetic engineering to answer these worldwide challenges.
has issue date	2017-03-31(xsd:dateTime)
bibo:doi	10.1016/s0001-4079(19)30502-3
bibo:pmid	32226055
has license	els-covid
sha1sum (hex)	63bfe3719fb216531ee41e021fc08f351168febc
schema:url	https://doi.org/10.1016/s0001-4079%2819%2930502-3
resource representing a document's title	Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins »
has PubMed Central identifier	PMC7095193
has PubMed identifier	32226055
schema:publication	Bulletin de l'Académie Nationale de Médecine
resource representing a document's body	covid:63bfe3719fb216531ee41e021fc08f351168febc#body_text
is schema:about of	named entity 'VACCINS' named entity 'DES' named entity 'COMMUNICATION' named entity 'VIS' named entity 'ACAD' named entity 'SCIENCES' named entity 'RECHERCHE' named entity 'Séance' named entity 'la question' named entity 'instar' named entity 'Formant' named entity 'la cible' named entity 'évolué' named entity 'virosomes' named entity 'la question' named entity 'le consortium' named entity 'la pyramide' named entity 'virosomes' named entity 'la modification' named entity 'virion' named entity 'aluminium' named entity 'la balance' named entity 'impulsion' named entity 'phagocytose' named entity '100 %' named entity 'permis' named entity 'dont' named entity 'C. diff' named entity 'mis' named entity 'du Nord' named entity 'zoonoses' named entity 'le monde' named entity 'liposomes' named entity 'dont' named entity 'végétal' named entity 'permet' named entity 'chikungunya' named entity 'activant' named entity 'le monde' named entity 'H1N1' named entity 'du Nord' named entity 'phase III' named entity 'la question' named entity 'Klebsiella pneumoniae' named entity 'virosomes' named entity 'INRA' named entity 'Lyon' named entity 'permet' named entity 'défiance' named entity 'Académie nationale de médecine' named entity 'Sciences' named entity 'recherche' named entity 'Séance' named entity 'vis-à-vis' named entity 'perspectives'
is part of of	covid:63bfe3719fb216531ee41e021fc08f351168febc#body_text SUMMARY The explosion of vaccines during the 20th century allowed the control of numerous infectious plagues but multiple challenges oppose conservation and extension of these successes. The hesitation of modern societies in front of vaccinations requires researches in life, human and social sciences in order to reach a better understanding of vaccines mechanism of action and to improve the tolerance and acceptability of vaccines and additives. The ageing of the populations and the increase of subjects at risk also require to improve the immunogenicity and the efficiency of existing vaccines. The constant emergence of new epidemics or the development of the antibio-resistance imposes innovation and development of new vaccines. The recent difficulties faced by the development of vaccines against malaria, tuberculosis or AIDS illustrate the necessity of moving beyond classical recipes and of elaborating new vectors and new adjuvants, of better understanding the heterogeneity of vaccine immunity and of developing alternative routes of immunization. Multidisciplinary researches using the most recent advances in molecular, structural and cellular biology, in microbiology, immunology and of genetic engineering to answer these worldwide challenges. Séance bi-académique de l’Académie nationale de médecine et de l’Académie des Sciences: « Confiance et défiance vis-à-vis des vaccins »

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software